Litcius/Paper detail

Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis

Daniele Focosi, Fabrizio Maggi, Scott A. McConnell, Arturo Casadevall

2022Antiviral Research64 citationsDOIOpen Access PDF

Topics & Concepts

PandemicVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)BiologyMedicineResistance (ecology)RNA-dependent RNA polymeraseRNAGeneticsGeneEcologyInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyViral Infections and Immunology Research
Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis | Litcius